Bank of America Securities analyst Bryan Spillane has reiterated their bullish stance on CL stock, giving a Buy rating on April 17.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Bryan Spillane’s rating is based on Colgate-Palmolive’s ability to demonstrate financial flexibility and resilience despite challenges such as tariffs impacting margins. The company managed to exceed earnings expectations in the first quarter, indicating strong performance potential. Spillane notes that the company’s management is effectively utilizing its profit and loss flexibility, which is expected to support continued growth.
Furthermore, Spillane maintains a positive outlook due to Colgate-Palmolive’s strategic initiatives, including innovation and pricing strategies, which are likely to drive organic sales improvement. The company’s ability to offset tariff impacts through alternative sourcing and cost-saving measures also contributes to the Buy rating. The valuation target of $110 reflects confidence in the company’s capacity to maintain its market share and deliver earnings growth, justifying a premium compared to its peers.
Spillane covers the Consumer Defensive sector, focusing on stocks such as Colgate-Palmolive, Keurig Dr Pepper, and Molson Coors. According to TipRanks, Spillane has an average return of 4.5% and a 57.37% success rate on recommended stocks.
In another report released on April 17, UBS also maintained a Buy rating on the stock with a $109.00 price target.